Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp) (NCT05375344) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Mobility and Voiding Exercises in Older Women With Urinary Incontinence (MoVEonUp)
United States375 participantsStarted 2022-06-09
Plain-language summary
A prospective, two-arm randomized clinical trial utilizing a multidimensional intervention to reduce falls in older women with Urinary Urge Incontinence. The intervention consist of general balance and strength training, bladder training and urge suppression, and home hazard assessments. The control group will receive informational booklets on fall prevention and behavioral treatment for urinary urge incontinence.
Who can participate
Age range
70 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female
* 70 or older
* Living independently in the community
* Willingness to be randomized.
* Ability to read and understand English
* Be able to provide informed consent
* Low physical activity (physically active for 30 minutes or more less than or equal to 2 days per week on average over the past 6 months) per PAS
* Ambulatory (defined as patient not confined to bed or wheelchair OR ability to walk with or without an assistive device)
* Self-reported moderate to severe urge-predominant UI based on the ICIQ-SF \> 6 (Q 1+2+3)
* Not planning to initiate new UI or overactive bladder (OAB) treatment during the study duration
* Capable of participation in an exercise program without exacerbating any pre-existing condition(s), as determined by the study PI or designee
Exclusion Criteria:
* Pelvic organ prolapse passed the hymen (per patient report)
* Undergoing active treatment for cancer (other than non-melanoma skin cancer)
* Uncorrected visual or hearing loss.
* Other urinary conditions or procedures that may affect continence status for example: urethral diverticulum, previous augmentation cystoplasty
* Progressive neurodegenerative disease e.g. Parkinson's disease, multiple sclerosis per patient report
* History of stroke or carotid sensitivity (i.e. syncopal falls) per patient report
* Unstable cardiac disease per patient report
* Fracture or joint replacement within the last six months per patient report
* Significant cognitive impairment (defined …
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in number of falls between the baseline visit and 1 year